These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23436390)

  • 1. Prenatal peptide treatment appears promising in Down syndrome mouse model.
    Levenson D
    Am J Med Genet A; 2013 Mar; 161A(3):ix. PubMed ID: 23436390
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal treatment prevents learning deficit in Down syndrome model.
    Incerti M; Horowitz K; Roberson R; Abebe D; Toso L; Caballero M; Spong CY
    PLoS One; 2012; 7(11):e50724. PubMed ID: 23209818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of learning deficit in a Down syndrome model.
    Incerti M; Toso L; Vink J; Roberson R; Nold C; Abebe D; Spong CY
    Obstet Gynecol; 2011 Feb; 117(2 Pt 1):354-361. PubMed ID: 21252750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome.
    Vink J; Auth J; Abebe DT; Brenneman DE; Spong CY
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):825-9. PubMed ID: 16150281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of synaptic failure and alleviation of learning and memory impairments in a trisomic mouse model of down syndrome.
    Blanchard J; Bolognin S; Chohan MO; Rabe A; Iqbal K; Grundke-Iqbal I
    J Neuropathol Exp Neurol; 2011 Dec; 70(12):1070-9. PubMed ID: 22082658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide T in treatment of AIDS.
    Wetterberg L; Alexius B; Sääf J; Sönnerborg A; Britton S; Pert C
    Lancet; 1987 Jan; 1(8525):159. PubMed ID: 2879991
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment with neuropeptides attenuates c-fos expression in a mouse model of fetal alcohol syndrome.
    Incerti M; Vink J; Roberson R; Abebe D; Spong CY
    Am J Perinatol; 2010 Oct; 27(9):743-8. PubMed ID: 20446212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-SAL and NAP: Two Peptides Sharing a SIP Domain.
    Gozes I; Sragovich S; Schirer Y; Idan-Feldman A
    J Mol Neurosci; 2016 Jun; 59(2):220-31. PubMed ID: 26816081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in AIDS patients on peptide T.
    Bridge TP; Heseltine PN; Parker ES; Eaton E; Ingraham LJ; Gill M; Ruff M; Pert CB; Goodwin FK
    Lancet; 1989 Jul; 2(8656):226-7. PubMed ID: 2568560
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of alcohol-induced developmental delays and learning abnormalities in a model of fetal alcohol syndrome.
    Endres M; Toso L; Roberson R; Park J; Abebe D; Poggi S; Spong CY
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1028-34. PubMed ID: 16157106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALSUntangled No. 34: GM604.
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):617-621. PubMed ID: 27043278
    [No Abstract]   [Full Text] [Related]  

  • 12. [Review of neurobehavioral effects of alcohol-related neurodevelopmental disorder in an animal model].
    Furuya H; Komaki Y; Okazaki I
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Feb; 41(1):15-22. PubMed ID: 16619845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice.
    Nakano-Kobayashi A; Awaya T; Kii I; Sumida Y; Okuno Y; Yoshida S; Sumida T; Inoue H; Hosoya T; Hagiwara M
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10268-10273. PubMed ID: 28874550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D
    Gomes FC; de Melo-Neto JS; Ferrari MFR; Carlos CP; Goloni-Bertollo EM; Pavarino ÉC
    Life Sci; 2019 Aug; 231():116537. PubMed ID: 31176774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comprehensive Analyses of Molecules with Altered Expression in the Brain of a Mouse Model of Down Syndrome for Identification of Pharmacotherapeutic Targets].
    Ishihara K
    Yakugaku Zasshi; 2017; 137(7):807-810. PubMed ID: 28674291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KDI tripeptide from laminin: a novel approach to treat neurodegenerative disorders.
    Carney S
    Drug Discov Today; 2005 Oct; 10(19):1268. PubMed ID: 16214670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the behavioral changes of sixty institutionalized female retardates during a three month course of treatment with monosodium glutamate.
    Babcock SD; Drake ME
    Train Sch Bull (Vinel); 1967 Aug; 64(2):49-57. PubMed ID: 4229905
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathophysiology of renal tubular obstruction: therapeutic role of synthetic RGD peptides in acute renal failure.
    Noiri E; Romanov V; Forest T; Gailit J; DiBona GF; Miller F; Som P; Oster ZH; Goligorsky MS
    Kidney Int; 1995 Nov; 48(5):1375-85. PubMed ID: 8544393
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of withdrawal symptoms with delta sleep-inducing peptide, a neuropeptide with potential agonistic activity on opiate receptors.
    Dick P; Grandjean ME; Tissot R
    Neuropsychobiology; 1983; 10(4):205-8. PubMed ID: 6328354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.